Clinical Trials Logo

Filter by:
NCT ID: NCT00837460 Completed - Stroke Clinical Trials

Effect of Rehabilitation of Patients With a Central Nervous System Lesion

Start date: September 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to analyse the prehensions deficits and the effect of prehension rehabilitation in central nervous system lesioned people

NCT ID: NCT00835770 Completed - Clinical trials for Relapsing-Remitting Multiple Sclerosis

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

ENDORSE
Start date: February 3, 2009
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the long-term safety profile of BG00012 (dimethyl fumarate). Secondary objectives of this study are to evaluate the long-term efficacy of BG00012 using clinical endpoints and disability progression, to evaluate further the long-term effects of BG00012 on multiple sclerosis (MS) brain lesions on magnetic resonance imaging (MRI) scans in participants who had MRI scans as part of Studies 109MS301 (NCT00420212) and 109MS302 (NCT00451451) and to evaluate the long-term effects of BG00012 on health economics assessments and the visual function test.

NCT ID: NCT00835744 Completed - Infertility Clinical Trials

Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles

cc versus FSH
Start date: August 2008
Phase: Phase 4
Study type: Interventional

The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induction cycles.

NCT ID: NCT00835185 Completed - Clinical trials for Metastatic Colorectal Cancer

Study of IMC-11F8 in Participants With Colorectal Cancer

Start date: August 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if IMC-11F8 in combination with chemotherapy is effective in treating colorectal cancer (CRC).

NCT ID: NCT00834041 Completed - Hypertension Clinical Trials

A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Start date: April 2009
Phase: Phase 1/Phase 2
Study type: Interventional

This first open-label study in a pediatric population was designed to evaluate aliskiren safety and pharmacokinetics after single and multiple dosing in 6-17 year old children with hypertension.

NCT ID: NCT00834002 Completed - Clinical trials for Acute Myeloid Leukemia (AML)

Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission

CCRG 05-001
Start date: March 2005
Phase: Phase 1
Study type: Interventional

RATIONALE: Vaccines made from a patient's white blood cells (dendritic cells) and a specific leukemia antigen (Wilms tumor antigen-1) may induce an effective immune response to kill residual leukemic cells and/or prevent leukemia relapse. PURPOSE: This phase I/II trial is studying the feasibility, safety and efficacy of intradermal mRNA-transfected dendritic cell vaccination therapy in patients with acute myeloid leukemia.

NCT ID: NCT00833950 Completed - Tinnitus Clinical Trials

Phase Out in Tinnitus Patients

Start date: March 2008
Phase: Phase 4
Study type: Interventional

Phase shift treatment is a new tinnitus therapy that aims at sound cancelling via complete or partial residual inhibition. This technique is based on the theory by Choy advocating that the induction of a sound wave with a 180 degree phase shift compared to the sound experienced by the patient could result in sound cancelling, likely by negation of the cortical perception of tinnitus. The aim is to determine the efficacy of the Phase Out treatment in pure tone and narrow band noise tinnitus patients.

NCT ID: NCT00833612 Completed - Clinical trials for Acute Myocardial Infarction (AMI)

Counterpulsation Reduces Infarct Size Pre-PCI for AMI

CRISP-AMI
Start date: December 2008
Phase: Phase 4
Study type: Interventional

Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.

NCT ID: NCT00833417 Completed - Clinical trials for Basal Cell Carcinoma

A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma

Start date: February 2009
Phase: Phase 2
Study type: Interventional

This was a Phase II, single-arm, two-cohort multicenter clinical trial evaluating the efficacy and safety of vismodegib (GDC-0449) in patients with advanced basal cell carcinoma. All patients received vismodegib until evidence of progression, intolerable toxicities most probably attributable to vismodegib, or withdrawal from the study.

NCT ID: NCT00833196 Completed - Clinical trials for Idiopathic Cervical Dystonia

Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia

Start date: February 2009
Phase:
Study type: Observational

A post marketing, international, multicenter, observational, prospective, longitudinal study. The purpose of the study is to describe cervical dystonia sub-types with their injection protocols and response to BoNT-A.